LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

NVS

145.93

+0.38%↑

AZN

182.32

+0.05%↑

LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

NVS

145.93

+0.38%↑

AZN

182.32

+0.05%↑

LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

NVS

145.93

+0.38%↑

AZN

182.32

+0.05%↑

LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

NVS

145.93

+0.38%↑

AZN

182.32

+0.05%↑

LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

NVS

145.93

+0.38%↑

AZN

182.32

+0.05%↑

Inicio・Lista de Acciones・Ventyx Biosciences Inc

Ventyx Biosciences Inc

Cerrado

13.99

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

13.99

Máximo

13.99

Métricas clave
By Trading Economics
Ingresos	4.2M -23M
Empleados	83
EBITDA	6.6M -23M

Recomendaciones
By TipRanks
Recomendaciones	Neutral
Estimación a 12 Meses	-4.43% downside

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	418M 1B
Apertura anterior	13.99
Cierre anterior	13.99

Ventyx Biosciences Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

12 mar 2026, 23:12 UTC

Acciones populares

Stocks to Watch: Adobe, Mission Produce, Buzzfeed, Ulta

12 mar 2026, 22:15 UTC

Ganancias

Wheaton Precious Metals Logs Higher 4Q Net Income, Boosts Dividend 18%

12 mar 2026, 21:42 UTC

Noticias de Eventos Importantes

Stryker Says Cyberattack Disruption Is Continuing

12 mar 2026, 21:29 UTC

Noticias de Eventos Importantes

Correction to War in Iran May Upend Brazil Central Bank's Plans Article

12 mar 2026, 21:27 UTC

Ganancias

Adobe CEO to Depart as AI Boosts Sales -- Update

12 mar 2026, 20:46 UTC

Ganancias

Adobe Posts Higher Sales With CEO Set to Depart

12 mar 2026, 20:21 UTC

Noticias de Eventos Importantes

Soybean Futures Higher on Instability in Iran --Daily Grain Highlights

12 mar 2026, 23:57 UTC

Charlas de Mercado

Gold Edges Higher Amid Ongoing Middle East Conflict -- Market Talk

12 mar 2026, 23:38 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

12 mar 2026, 23:38 UTC

Charlas de Mercado

Nikkei May Fall, Tracking Wall Street's Losses -- Market Talk

12 mar 2026, 22:13 UTC

Ganancias

Orient Overseas: Tariff Measures, Trade Tensions Weighed on Results >0316.HK

12 mar 2026, 22:13 UTC

Ganancias

Orient Overseas: Middle East Situation Have Added to Future Uncertainity >0316.HK

12 mar 2026, 22:13 UTC

Ganancias

Orient Overseas: Charter Market Remains Exceptionally Tight With Vessels in Short Supply >0316.HK

12 mar 2026, 22:13 UTC

Ganancias

Orient Overseas 2025 Rev $9.72B Vs. $10.70B >0316.HK

12 mar 2026, 22:13 UTC

Ganancias

Orient Overseas 2025 Net $1.51B Vs. Net $2.58 >0316.HK

12 mar 2026, 22:13 UTC

Charlas de Mercado

Ganancias

Global Equities Roundup: Market Talk

12 mar 2026, 22:13 UTC

Charlas de Mercado

Ganancias

Adobe Says Customers Want to Try AI Products for Free First -- Market Talk

12 mar 2026, 21:16 UTC

Adquisiciones, fusiones, absorciones

Alexander & Baldwin: JV Formed by Affil of MW Group and Funds Affiliated With Blackstone and DivcoWest Completed Acquisition of All Outstanding A&B Common Shrs >ALEX

12 mar 2026, 21:04 UTC

Ganancias

Adobe Earnings Beat Is Overshadowed by CEO Departure. The Stock Is Sliding. -- Barrons.com

12 mar 2026, 21:02 UTC

Ganancias

Wheaton Precious Metals 4Q Adj EPS $1.22 >WPM

12 mar 2026, 21:02 UTC

Ganancias

Wheaton Precious Metals 4Q Sales $865M >WPM

12 mar 2026, 21:02 UTC

Ganancias

Wheaton Precious Metals 4Q Net $558.3M >WPM

12 mar 2026, 21:02 UTC

Ganancias

Wheaton Precious Metals 4Q EPS $1.23 >WPM

12 mar 2026, 20:57 UTC

Charlas de Mercado

Noticias de Eventos Importantes

No Need For Canada Rate Increases Amid Jump in Bond Yields -- Market Talk

12 mar 2026, 20:50 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

12 mar 2026, 20:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

12 mar 2026, 20:15 UTC

Adquisiciones, fusiones, absorciones

Eaton Completes Acquisition Of Leading Liquid-cooling Solutions Provider Boyd Thermal, Creating An Industry-leading Grid-to-chip Solution For Data Centers >ETN

12 mar 2026, 20:10 UTC

Ganancias

Adobe Sees 2Q Rev $6.43B-$6.48B >ADBE

12 mar 2026, 20:05 UTC

Ganancias

Adobe 1Q Rev $6.4B >ADBE

12 mar 2026, 20:05 UTC

Ganancias

Adobe Sees 2Q Adj EPS $5.80-Adj EPS $5.85 >ADBE

Comparación entre iguales

Cambio de precio

Ventyx Biosciences Inc previsión

Precio Objetivo

By TipRanks

-4.43% descenso

Estimación a 12 Meses

Media 13.38 USD -4.43%

Máximo 14 USD

Mínimo 9 USD

De acuerdo con 8 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Ventyx Biosciences Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

8 ratings

Comprar

Mantener

Vender

De acuerdo con 8 analistas que ofrecen calificaciones bursátiles a para Ventyx Biosciences Inc Dist en los últimos 3 meses.

Finanzas

Acerca de Ventyx Biosciences Inc

Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates to address a range of inflammatory diseases. The company's lead clinical product candidate is VTX958, a selective allosteric tyrosine kinase type 2 inhibitor for psoriasis, psoriatic arthritis, and Crohn's disease. It is also developing VTX002, a sphingosine 1 phosphate receptor modulator that is in Phase II clinical trials for the treatment of ulcerative colitis; and VTX2735, a peripheral-targeted NOD-like receptor protein 3 inflammasome inhibitor to treat patients with cryopyrin-associated periodic syndrome. In addition, the company develops VTX3232, a CNS-penetrant NLRP3 inhibitor. Ventyx Biosciences, Inc. was incorporated in 2018 and is based in San Diego, California.